IMMUNE NETWORK

  • 제9권2호
  • /
  • Pages.64-73
  • /
  • 2009
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지
DOI QR코드

DOI QR Code

15-Deoxy-${\Delta}^{12,14}$-Prostaglandin $J_2$ Upregulates the Expression of LPS-Induced IL-8/CXCL8 mRNA in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats

  • Kim, Jung-Hae (Department of Microbiology, College of Medicine, and Aging-associated Vascular Disease Research Center, Yeungnam University) ;
  • Kim, Hee-Sun (Department of Microbiology, College of Medicine, and Aging-associated Vascular Disease Research Center, Yeungnam University)
  • 투고 : 2009.01.28
  • 심사 : 2009.03.04
  • 발행 : 2009.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: 15d-$PGJ_2$ has been known to act as an anti-inflammatory agent and has anti-hypertensive effects. As a result of these properties, we examined the effect of 15d-$PGJ_2$ on the LPS-induced IL-8/CXCL8 mRNA expression in VSMCs from SHR. Methods: Effect and action mechanism of 15d-$PGJ_2$ on the expression of LPS-induced IL-8/CXCL8 mRNA in VSMCs from SHR and WKY were examined by using real-time polymerase chain reaction, electrophoretic mobility shift assay for NF-${\kappa}B$ avtivity, Western blotting analysis for ERK and p38 phosphorylation and flow cytometry for NAD(P)H oxidase activity. Results: 15d-$PGJ_2$ decreased the expression of LPS-induced IL-8/CXCL8 mRNA in WKY VSMCs, but increased the expression of LPS-induced IL-8/CXCL8 mRNA in SHR VSMCs. The upregulatory effect of 15d-$PGJ_2$ in SHR VSMCs was mediated through PPAR${\gamma}$, and dependent on NF-${\kappa}B$ activation and ERK phosphorylation. However, inhibition of the p38 signaling pathway augmented the upregulatory effect of 15d-$PGJ_2$ on LPS-induced IL-8/CXCL8 mRNA. A NAD(P)H oxidase inhibitor inhibited the upregulatory effect of 15d-$PGJ_2$ on LPS-induced IL-8/CXCL8 mRNA expression in SHR VSMCs, and an increase in NAD(P)H oxidase activity was detected in SHR VSMCs treated with 15d-$PGJ_2$/LPS. Conclusion: Our results indicate that the upregulatory effect of 15d-$PGJ_2$ on LPS-induced IL-8/CXCL8 expression in SHR VSMCs is mediated through the PPAR${\gamma}$ and ERK pathway, and may be related to NAD(P)H oxidase activity. However, p38 inactivation may also play an important role in 15d-$PGJ_2$/LPS-induced IL-8/CXCL8 expression in SHR VSMCs.

키워드

참고문헌

  1. Alexander RW: Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25;155-161, 1995 https://doi.org/10.1161/01.HYP.25.2.155
  2. Capers Q 4th, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30;1397-1402, 1997 https://doi.org/10.1161/01.HYP.30.6.1397
  3. Rodr$\acute{i}$guez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ: Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol 286;F606-F616, 2004 https://doi.org/10.1152/ajprenal.00269.2003
  4. Zhang Y, Griendling KK, Dikalova A, Owens GK, Talyor WR: Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 46;732-737, 2005 https://doi.org/10.1161/01.HYP.0000182660.74266.6d
  5. Gerszten RE: Pleiotropic effects of chemokines in vascular lesion development. Artherioscler Thromb Vasc Biol 22; 528-529, 2002 https://doi.org/10.1161/01.ATV.0000015099.41408.31
  6. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338;436-445, 1998 https://doi.org/10.1056/NEJM199802123380706
  7. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398; 718-723, 1999 https://doi.org/10.1038/19546
  8. Boekholdt S, Peters R, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw K: IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 24;1503-1508, 2004 https://doi.org/10.1161/01.ATV.0000134294.54422.2e
  9. Buemi M, Marino D, Floccari F, Ruello A, Nosto L, Aloisi C, Marino MT, Di Pasquale G, Corica F, Frisina M: Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of $K^+$ in erythrocytes from subjects with essential hypertension. Curr Med Res Opin 20;19-24, 2004 https://doi.org/10.1185/030079903125002720
  10. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS: Upregulation of Interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31;515-523, 2008 https://doi.org/10.1291/hypres.31.515
  11. Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL: Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 43;48-56, 2004 https://doi.org/10.1161/01.HYP.0000103629.01745.59
  12. Fukuda N, Hu WY, Teng J, Chikara S, Nakayama K, Kanmatsuse K: Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 163;229-239, 2002 https://doi.org/10.1016/S0021-9150(02)00014-X
  13. Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T: Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats. Hypertens Res 28;255-262, 2005 https://doi.org/10.1291/hypres.28.255
  14. Calnek DS, Mazzella L, Roser S, Roman J, Hart CM: Peroxisome proliferatorsactivated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23;52-57, 2003 https://doi.org/10.1161/01.ATV.0000044461.01844.C9
  15. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391; 82-86, 1998 https://doi.org/10.1038/34184
  16. Chastine Bell-Parikh L, Ide T, Lawson JA, Mcncmara P, Reilly M, Fitzgerald GA: Biosynthesis of 15-deoxy-delta 12,14- PGJ2 and the ligation of PPARgamma. J Clin Invest 112;945-955, 2003 https://doi.org/10.1172/JCI200318012
  17. Benkirane K, Amiri F, Diep QN, Mabrouk ME, Schiffrin EL:PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. Am J Physiol Heart Circ Physiol 290;H390-H397, 2006 https://doi.org/10.1152/ajpheart.00662.2005
  18. Law RE, Goetze S, Xi, XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA: Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation 101;1311-1318, 2000 https://doi.org/10.1161/01.CIR.101.11.1311
  19. Lim HJ, Lee KS, Lee S, Park JH, Choi HE, Go SH, Kwak HJ, Park HY: 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. Toxicol and Appl Pharmacol 223;20-27, 2007 https://doi.org/10.1016/j.taap.2007.04.019
  20. Cuzzocrea S, Wayman NS, Mazzon E, Dugo L, Paola R, Serraino I, Britti D, Chatterjee PK, Caputi AP, Thiemermann C: The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol 61;997-1007, 2002 https://doi.org/10.1124/mol.61.5.997
  21. Reilly CM, Oates JC, Suidan J, Crosby MB, Halushka PV, Gilkeson GS: Prostaglandin J2 inhibition of mesangial cell iNOS expression. Clin Immunol 3;337-345, 2001
  22. Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R: 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. Kideny Int 61;1957-1967, 2002 https://doi.org/10.1046/j.1523-1755.2002.00351.x
  23. Fu Y, Luo N, Lopes-Virella MF: Upregulation of interleukin-8 expression by prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages. Atherosclerosis 160;11-20, 2002 https://doi.org/10.1016/S0021-9150(01)00541-X
  24. Harris SG, Smith RS, Phipps RP: 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J Immunol 168; 1372-1379, 2002 https://doi.org/10.4049/jimmunol.168.3.1372
  25. Kim HY, Kim HK, Kim JR, Kim HS: Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. Immunol Cell Biol 83;286-293, 2005 https://doi.org/10.1111/j.1440-1711.2005.01329.x
  26. Kim HY, Kim HS: Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. Immunol Cell Biol 85;60-67, 2007 https://doi.org/10.1038/sj.icb.7100001
  27. Kelly G, Robert B, Chris R, Gary G, Perry H, James C:Differential effects of 15-deoxy-Delta(12,14)-PGJ2 and a peroxisome proliferators-activated receptor gamma agonist on macrophage activation. J Leukoc Biol 69;631-638, 2001
  28. Ricote M, Huang JT, Welch JS, Glass CK: The peroxisome proliferator-activated receptor gamma (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 66;733-739, 1999 https://doi.org/10.1002/jlb.66.5.733
  29. Zhang X, Wang JM, Gong WH, Mukaida N, Young HA:Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. J Immunol 166;7104-7111, 2001 https://doi.org/10.4049/jimmunol.166.12.7104
  30. Wakino S, Hayashi H, Kanda T, Tatematsu S, Homma K, Yoshioka K, Taksmatsu I, Saruta T: Peroxisome proliferatior-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circulation 95;e45-e55, 2004 https://doi.org/10.1161/01.RES.0000142313.68389.92
  31. Guyton K, Bond R, Reilly C, Gileson G, Halushka P, Cook J: Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activatedreceptor gamma agonist on macrophage activation. J Leukoc Biol 69;631-638, 2001
  32. Kim HY, Kim JR, Kim HS: Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. J Microbiol Biotech 18;1170-1178, 2008
  33. Bureau F, Desmet C, Melotte D, Jaspar F, Volanti C, Vanderplasschen A, Pastoret PP, Piette J, Lekeux P: A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. J Immunol 168;5318-5325, 2002 https://doi.org/10.4049/jimmunol.168.10.5318
  34. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391;79-82, 1998 https://doi.org/10.1038/34178
  35. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Galss CK: 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 97;4844-4849, 2000 https://doi.org/10.1073/pnas.97.9.4844
  36. Wilmer WA, Dixon C, Lu L, Hilbelink T, Rovin BH: A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. Biochem Biophys Res Comm 281;57-62, 2001 https://doi.org/10.1006/bbrc.2001.4301
  37. Takeda K, Ichiki T, Tokunou T, Iino N, Takeshita A: 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem 276;48950-48955, 2001 https://doi.org/10.1074/jbc.M108722200
  38. Jung YD, Fan F, McConkey DJ, Jean ME, Liu W, Reinmuth N, Stoeltzing O, Ahmad SA, Parikh AA, Mukaida N, Ellis LM: Role of p38 MAPK, AP-1 and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells. Cytokine 18;206-213, 2002 https://doi.org/10.1006/cyto.2002.1034
  39. Zhao ML, Brosnan CF, Lee SC: 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. J Neuroimmunol 153;132-142, 2004 https://doi.org/10.1016/j.jneuroim.2004.05.003
  40. Thannickal VJ, Fanburg BL: Reative oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279;L1005-L1028, 2000
  41. Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM: Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinkike growth factor-1 receptor transactivation. Am J Hyertension 18;81-87, 2005 https://doi.org/10.1016/j.amjhyper.2004.09.001
  42. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85;753-766, 1999 https://doi.org/10.1161/01.RES.85.8.753
  43. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK: Angiotensin II stimulation of NAD(P)H oxi dase activity upstream mediators. Circ Res 91;406-413, 2002 https://doi.org/10.1161/01.RES.0000033523.08033.16
  44. Touyz RM, Schiffrin EL: Ang II-stimulated generation of reactive oxygen species in Human vascular smooth muscle cells in mediated via PLD-dependent pathways. Hypertension 34;976-982, 1999 https://doi.org/10.1161/01.HYP.34.4.976